https://pipelinereview.com/centrexion-therapeutics-announces-new-6-month-data-demonstrating-significant-and-durable-pain-relief-with-cntx-4975-for-treatment-of-moderate-to-severe-knee-osteoarthritis-pain/
Centrexion Therapeutics Announces New 6-Month Data Demonstrating Significant and Durable Pain Relief with CNTX-4975 for Treatment of Moderate to Severe Knee Osteoarthritis Pain